Alivus Life Sciences Limited

Alivus Life Sciences Limited is a pharmaceutical company specializing in the development, manufacturing, and marketing of high-value, non-commoditized active pharmaceutical ingredients (APIs) primarily targeting chronic therapeutic areas. The firm offers a diverse portfolio of around 151 API molecules used across key therapy segments such as cardiovascular diseases, central nervous system disorders, diabetes, oncology, pain management, and anti-infectives. Additionally, it provides contract development and manufacturing services to multinational and specialty pharmaceutical companies, supporting their drug development needs. With manufacturing facilities in India and a global footprint supplying markets in Europe, North America, Latin America, Japan, and beyond, Alivus Life Sciences plays an important role in the global pharmaceutical supply chain. The company, a subsidiary of Nirma Limited and formerly known as Glenmark Life Sciences Limited until late 2024, combines R&D expertise with integrated support to deliver quality APIs and contract services to partners worldwide.